Schedule 13D ownership disclosure

NEOPROBE CORP

Security class unavailable · CUSIP: 640518106

Event date: 2016-02-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.5900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-497413
Form type
SC 13D
Filer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK
CIK 810509
Filed
Mar 09, 2016
Reporting period
Feb 23, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub